IntelliSep, a Diagnostic Test for Sepsis, Receives Funding to Expand Reach
IntelliSep, a revolutionary diagnostic test for sepsis, has just received a major funding boost. The company will use the funds to expand the reach of its sepsis-focused diagnostic test, IntelliSep, to help more patients receive the vital care they need.
Sepsis is a life-threatening condition in which the body’s response to infection is out of control. It is a leading cause of death in the United States, with an estimated 1.7 million cases each year and a mortality rate of 28.9%. Sepsis can be difficult to diagnose, as its symptoms are often similar to those of other conditions, such as the flu.
IntelliSep is a diagnostic test developed by a team of scientists and doctors at the University of California, San Francisco. It is designed to detect sepsis quickly and accurately. The test uses a combination of biomarkers, including C-reactive protein and procalcitonin, to accurately diagnose sepsis.
The funding will enable IntelliSep to expand its reach to more hospitals and health care centers. This will allow more patients to receive the vital care they need to survive sepsis. Additionally, the funding will allow IntelliSep to continue its research into sepsis and develop new treatments and therapies.
The team at IntelliSep is excited to be able to use the funding to expand its reach and continue its research. Dr. Mark Smith, one of the scientists at IntelliSep, said, “We are thrilled to be able to use the funding to expand our reach and continue our research into sepsis. We believe that IntelliSep can help save lives and we are excited to be able to make it available to more patients.”
IntelliSep’s diagnostic test is a revolutionary tool that could help save countless lives. The team at IntelliSep is dedicated to providing the best care possible to those suffering from sepsis and is excited to be able to use the funding to expand its reach and continue its research. This funding will help IntelliSep continue to make a difference in the lives of those affected by sepsis.
